Literature DB >> 6401493

Repeated renal failure with use of captopril in a cystinotic renal allograft recipient.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6401493      PMCID： PMC1546420          DOI： 10.1136/bmj.286.6359.145-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  7 in total

1.  Reversible renal failure during treatment with captopril.

Authors:  P R Farrow; R Wilkinson
Journal:  Br Med J       Date:  1979-06-23

2.  Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

Authors:  H Gavras; H R Brunner; G A Turini; G R Kershaw; C P Tifft; S Cuttelod; I Gavras; R A Vukovich; D N McKinstry
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

3.  Control of glomerular filtration rate by renin-angiotensin system.

Authors:  J E Hall; A C Guyton; T E Jackson; T G Coleman; T E Lohmeier; N C Trippodo
Journal:  Am J Physiol       Date:  1977-11

4.  Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog.

Authors:  W P Anderson; C I Johnston; P I Korner
Journal:  J Physiol       Date:  1979-02       Impact factor: 5.182

5.  Reversible renal failure during treatment with captopril.

Authors:  P Collste; K Haglund; G Lundgren; G Magnusson; J Ostman
Journal:  Br Med J       Date:  1979-09-08

6.  Captopril: reversible renal failure with severe hyperkalaemia.

Authors:  A Grossman; D Eckland; P Price; C R Edwards
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

7.  Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.

Authors:  D V Hamilton; D B Evans; G Maidment; J S Pryor
Journal:  J R Soc Med       Date:  1981-05       Impact factor: 5.344
  7 in total
  2 in total

Review 1.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

2.  Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.

Authors:  G P Reams; J H Bauer
Journal:  Drugs       Date:  1985       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.